A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2001
11/29/2001	WO2001089502A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	WO2001089471A2 External skin preparations for suppressing sebum secretion
11/29/2001	WO2001089469A1 Topical composition containing at least one aryl oxime, and method for the preparation thereof
11/29/2001	WO2001089468A1 Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reactions of the skin
11/29/2001	WO2001089467A1 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001089450A2 Treating musculoskeletal disorders using lp85 and analogs thereof
11/29/2001	WO2001089282A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001060835A8 Purine derivatives
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001038347A3 Peptides having antiangiogenic activity
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2000061162A9 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000041548A3 Methods for glucagon suppression
11/29/2001	WO2000040210A3 Topical compositions comprising protected functional thiols
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	WO2000010548A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001	US20010047082 Soluble keratin peptide
11/29/2001	US20010047035 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (NO) in specimens taken from the patient under controlled conditions
11/29/2001	US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001	US20010047019 3-Aminopyrazole inhibitors of cyclin dependent kinases
11/29/2001	US20010047018 Novel benzosultam oxazolidinone antibacterial agents
11/29/2001	US20010047004 Oxazolidinone thioamides with piperazine amide substituents
11/29/2001	US20010046995 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046987 Potent activity against Grampositive and Gramnegative bacteria
11/29/2001	US20010046509 Use of cinnamic acid or of its derivatives in a cosmetic firming composition
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	EP1143949A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001	EP1143916A3 Topical compositions comprising protected functional thiols
11/29/2001	DE10025558A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung Topical composition comprising at least one aryl oxime, and processes for their preparation
11/29/2001	DE10025553A1 Zusammensetzung, enthaltend mindestens ein Aryloxim und mindestens einen Wirkstoff zur Behandlung von Akne und ihre Verwendung Composition containing at least one aryl oxime, and at least one active substance for the treatment of acne and their use
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410987A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409929A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408145A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2405871A1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP1156765A1 Hemostatic polymer useful for rapid blood coagulation and hemostasis
11/28/2001	EP1073412B1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324380A Gel composition
11/28/2001	CN1324364A Phosphoglycolipid and methods for its use
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324246A Method for enhancing wound healing
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324235A Compositions of and process for producing isotretinoin having low particle size
11/28/2001	CN1323623A Multipurpose medicine made of bamboo liquid and honey and its prepn.
11/28/2001	CN1323616A Medicine for treating burns, scalds and body odour
11/28/2001	CN1323615A Bathing talcum powder
11/28/2001	CN1323613A Traditional Chinese medicine for 3D process treating condyloma acuminata
11/28/2001	CN1323610A Proriasis treating Yinxieling capsule
11/28/2001	CN1323606A Wound curing and swelling-eliminating tranditional Chinese medicine ointment and its pharmaceutical application
11/28/2001	CN1323596A Toxin-absorbing drying medicine
11/28/2001	CN1323580A Health giving bathing mud
11/28/2001	CN1075384C Chinese medicine preparation for treating acne
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323201 Compounds for inhibition of ceramide-mediated signal transduction
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6322825 Compositions containing thymol and carvacrol and methods of treating gastrointestinal infections with the compositions
11/27/2001	US6322798 Container closed with a cap containing ascorbic acid and perforable and/or detachable separator; toning, stimulation, regeneration, moisturizing effects, smoothness, softness attenuation of wrinkles, firmness, clarity of skin
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides

1 ... 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 ... 1065